abstract |
FIELD: medicine.SUBSTANCE: present invention refers to medicine, particularly to pharmaceutics, namely to a pharmaceutical composition based on triiodomethane and aluminosilicate carrier in ratio of triiodomethane - 0.5–45 wt. %, aluminosilicate carrier - 55–99.5 wt. %.EFFECT: disclosed compositions are effective for local application in preventing and treating wounds, damages, inflammations on skin, mucous tissues or in oral cavity.10 cl, 2 tbl, 1 dwg |